Literature DB >> 2473335

Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit.

T D Warner1, J A Mitchell, G de Nucci, J R Vane.   

Abstract

We have previously shown that porcine endothelin (ET-1) releases endothelium-derived relaxing factor (EDRF) in the rat isolated perfused mesentery. Here we show that both ET-1 (1-100 pmol) and rat endothelin (ET-3, 1-300 pmol) release EDRF in this preparation and that ET-1 releases EDRF from the luminally perfused aorta of the rabbit. Furthermore, we confirm that, as a pressor agent, ET-1 is greater than 10 times more potent than ET-3. Vasodilatations in the rat isolated perfused mesentery in response to ET-1 and ET-3 were due to the release of EDRF since they were inhibited by removal of the endothelium, methylene blue (100 microM), or hemoglobin (30 microM). ET-3 was more selective than ET-1 as a vasodilator because ET-1 induced vasodilatations were limited and in the higher doses overwhelmed by concurrent vasoconstrictions. Release of EDRF from the rabbit aorta in response to ET-1 but not to other agonists (acetylcholine, substance P, or adenosine diphosphate) was potentiated by infusion of potassium chloride (3 mM). Bay K 8644 failed to release EDRF in either system or to constrict the nondepolarized rat mesentery. Thus, both ET-1 and ET-3 release EDRF by activation of receptors or channels that differ from dihydropyridine-sensitive calcium channels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473335     DOI: 10.1097/00005344-198900135-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  39 in total

1.  The role of myocardial perfusion imaging in vascular endothelial dysfunction.

Authors:  V Dilsizian
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  An immunohistochemical study of endothelial cell heterogeneity in the rat: observations in "en face" Häutchen preparations.

Authors:  A Tomlinson; H Van Vlijmen; A Loesch; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-01       Impact factor: 5.249

3.  Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition.

Authors:  Stephane L Bourque; Heather A Whittingham; Susan E Brien; Sandra T Davidge; Michael A Adams
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 4.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 5.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

6.  Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

7.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  The involvement of endothelial dysfunction, nitric oxide and prostanoids in the rat gastric microcirculatory responses to endothelin-1.

Authors:  J Lopez-Belmonte; B J Whittle
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

10.  Involvement of cyclo-oxygenase-generated vasodilating eicosanoid(s) in addition to nitric oxide in endothelin-1-induced endothelium-dependent vasorelaxation in guinea pig aorta.

Authors:  H Matsuda; S Beppu; F Ohmori; M Yamada; K Miyatake
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.